TP53 mutated AML subclones exhibit engraftment in a humanized bone marrow ossicle mouse model

Ítems similars

• Clinical implications of subclonal TP53 mutations in acute myeloid leukemia
  per: Prochazka, Katharina T., et al.
  Publicat: (2019)
• Detection of AML-specific TP53 mutations in bone marrow–derived mesenchymal stromal cells cultured under hypoxia conditions
  per: Müller, Marian, et al.
  Publicat: (2019)
• Functional Classification of TP53 Mutations in Acute Myeloid Leukemia
  per: Dutta, Sayantanee, et al.
  Publicat: (2020)
• Acute Myeloid Leukemia and Myelodysplastic Syndromes with TP53 Aberrations – A Distinct Stem Cell Disorder
  per: Sill, Heinz, et al.
  Publicat: (2020)
• AML chemoresistance: The role of mutant TP53 subclonal expansion and therapy strategy
  per: Yan, Bowen, et al.
  Publicat: (2020)